Friday, February 13, 2009
AstraZeneca gets USFDA nod for Metoprolol Succinate tablets
The Anglo-Swedish drug maker, AstraZeneca has received final approval from the US Food and Drug Administration (USFDA) to market Metoprolol Succinate tablets, in the strength of EQ 50 mg tartrate, EQ 100 mg tartrate, EQ 200mg tartrate and EQ 25 mg tartrate.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment